Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (751-760 of 1,482) with videos related to

Pageof 149
Sort By:
Cancer|March 18, 2025
A retrospective study of outcomes across time and treatment regimens in newly diagnosed, FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemiaAlexandre Bazinet, Alex Bataller, Tapan Kadia, et al.
Med (New York, N.Y.)|October 25, 2021
Tuberculosis endotypes to guide stratified host-directed therapyAndrew R DiNardo, Tomoki Nishiguchi, Sandra L Grimm, et al.
Pathogens & Immunity|June 28, 2024
A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant TuberculosisNika Zielinski, Dragos Baiceanu, Antonela Dragomir, et al.
Diabetes Care|October 17, 2013
Long-term effects of the booster-enhanced READY-Girls preconception counseling program on intentions and behaviors for family planning in teens with diabetesDenise Charron-Prochownik, Susan M Sereika, Dorothy Becker, et al.
Cancer|October 12, 2018
Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemiaRita Assi, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Frontiers in Oncology|May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We StandAlessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Blood Neoplasia|June 2, 2025
Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMMLSamuel Urrutia, Prithviraj Bose, Yesid Alvarado, et al.
Global Biogeochemical Cycles|January 10, 2017
A multi-year estimate of methane fluxes in Alaska from CARVE atmospheric observationsScot M Miller, Charles E Miller, Roisin Commane, et al.
Blood Cells, Molecules & Diseases|May 29, 2020
Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the HFE p.Cys282Tyr mutationAline Morgan Alvarenga, Nathália Kozikas da Silva, Paula Fernanda Silva Fonseca, et al.
Blood|October 25, 2023
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remissionElias Jabbour, Fadi G Haddad, Nicholas J Short, et al.
Pageof 149

Showing results (751-760 of 1,482) with videos related to

Sort By:
Pageof 149
Cancer|March 18, 2025
A retrospective study of outcomes across time and treatment regimens in newly diagnosed, FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemiaAlexandre Bazinet, Alex Bataller, Tapan Kadia, et al.
Med (New York, N.Y.)|October 25, 2021
Tuberculosis endotypes to guide stratified host-directed therapyAndrew R DiNardo, Tomoki Nishiguchi, Sandra L Grimm, et al.
Pathogens & Immunity|June 28, 2024
A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant TuberculosisNika Zielinski, Dragos Baiceanu, Antonela Dragomir, et al.
Diabetes Care|October 17, 2013
Long-term effects of the booster-enhanced READY-Girls preconception counseling program on intentions and behaviors for family planning in teens with diabetesDenise Charron-Prochownik, Susan M Sereika, Dorothy Becker, et al.
Cancer|October 12, 2018
Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemiaRita Assi, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Frontiers in Oncology|May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We StandAlessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Blood Neoplasia|June 2, 2025
Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMMLSamuel Urrutia, Prithviraj Bose, Yesid Alvarado, et al.
Global Biogeochemical Cycles|January 10, 2017
A multi-year estimate of methane fluxes in Alaska from CARVE atmospheric observationsScot M Miller, Charles E Miller, Roisin Commane, et al.
Blood Cells, Molecules & Diseases|May 29, 2020
Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the HFE p.Cys282Tyr mutationAline Morgan Alvarenga, Nathália Kozikas da Silva, Paula Fernanda Silva Fonseca, et al.
Blood|October 25, 2023
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remissionElias Jabbour, Fadi G Haddad, Nicholas J Short, et al.
Pageof 149